Engineered production of iso-migrastatin in heterologous Streptomyces hosts
- PMID: 19010685
- PMCID: PMC3075207
- DOI: 10.1016/j.bmc.2008.10.074
Engineered production of iso-migrastatin in heterologous Streptomyces hosts
Abstract
Glutarimide-containing polyketides such as migrastatin (MGS) are well known for their ability to inhibit tumor cell migration. We have previously shown that MGS is derived from iso-migrastatin (iso-MGS) via a H(2)O-mediated ring-expansion rearrangement. A bacterial artificial chromosome (BAC) library of Streptomyces platensis NRRL18993, an iso-MGS producer, was constructed. From this library, pBS11001, a BAC clone harboring the intact iso-MGS biosynthetic gene cluster, was identified. Mobilization of pBS11001 into five heterologous Streptomyces hosts afforded recombinant strains, SB11001, SB11002, SB11003, SB11004, and SB11005, respectively. Under a standard set of media and fermentation conditions, the recombinant strains all produced the same profile of iso-MGS as that of S. platensis NRRL18993. These findings highlight the strength and flexibility of the BAC-based technology for natural product production and engineering in heterologous Streptomyces model hosts.
Figures




References
-
- Thomas MG, Bixby KA, Shen B. In: Antitumor Agents from Natural Products. Kingston DGI, Cragg GM, Newman DJ, editors. Boca Rato, FL: CRC Press; 2005. pp. 519–551.
-
- Van Lanen S, Shen B. Drug Discov. Today: Technol. 2006;1:409–436. - PubMed
-
- Van Lanen S, Shen B. Curr. Opinion Microbiol. 2006;9:252–260. - PubMed
-
- Van Lanen S, Shen B. Curr. Opinion Drug Discov Devel. 2008;11:186–195. - PubMed
-
- Wenzel SC, Muller R. Curr. Opinion Biotechnol. 2005;16:594–606. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources